BACKGROUND: There is conflicting evidence about comorbid personality pathology in depression treatments. AIMS: To test the effects of antidepressant drugs and cognitive therapy in people with depression distinguished by the presence or absence of personality disorder. METHOD: Random assignment of 180 out-patients with depression to 16 weeks ofantidepressant medication or cognitive therapy. Random assignment of medication responders to continued medication or placebo, and comparison with cognitive therapy responders over a 12-month period. RESULTS: Personality disorder status led to differential response at 16 weeks; 66% v. 44% (antidepressants v. cognitive therapy respectively) for people with personality disorder, and 49% v. 70% (antidepressants v. cognitive therapy respectively) for people without personality disorder. For people with personality disorder, sustained response rates over the 12-month follow-up were nearly identical (38%) in the prior cognitive therapy and continuation-medication treatment arms. People with personality disorder withdrawn from medication evidenced the lowest sustained response rate (6%). Despite the poor response of people with personality disorder to cognitive therapy, nearly all those who did respond sustained their response. CONCLUSIONS: Comorbid personality disorder was associated with differential initial response rates and sustained response rates for two well-validated treatments for depression.
RCT Entities:
BACKGROUND: There is conflicting evidence about comorbid personality pathology in depression treatments. AIMS: To test the effects of antidepressant drugs and cognitive therapy in people with depression distinguished by the presence or absence of personality disorder. METHOD: Random assignment of 180 out-patients with depression to 16 weeks of antidepressant medication or cognitive therapy. Random assignment of medication responders to continued medication or placebo, and comparison with cognitive therapy responders over a 12-month period. RESULTS:Personality disorder status led to differential response at 16 weeks; 66% v. 44% (antidepressants v. cognitive therapy respectively) for people with personality disorder, and 49% v. 70% (antidepressants v. cognitive therapy respectively) for people without personality disorder. For people with personality disorder, sustained response rates over the 12-month follow-up were nearly identical (38%) in the prior cognitive therapy and continuation-medication treatment arms. People with personality disorder withdrawn from medication evidenced the lowest sustained response rate (6%). Despite the poor response of people with personality disorder to cognitive therapy, nearly all those who did respond sustained their response. CONCLUSIONS: Comorbid personality disorder was associated with differential initial response rates and sustained response rates for two well-validated treatments for depression.
Authors: Peter A Johnson; Robin A Hurley; Chawki Benkelfat; Sabine C Herpertz; Katherine H Taber Journal: J Neuropsychiatry Clin Neurosci Date: 2003 Impact factor: 2.198
Authors: C Salzman; A N Wolfson; A Schatzberg; J Looper; R Henke; M Albanese; J Schwartz; E Miyawaki Journal: J Clin Psychopharmacol Date: 1995-02 Impact factor: 3.153
Authors: R D Gibbons; D Hedeker; I Elkin; C Waternaux; H C Kraemer; J B Greenhouse; M T Shea; S D Imber; S M Sotsky; J T Watkins Journal: Arch Gen Psychiatry Date: 1993-09
Authors: I Elkin; M T Shea; J T Watkins; S D Imber; S M Sotsky; J F Collins; D R Glass; P A Pilkonis; W R Leber; J P Docherty Journal: Arch Gen Psychiatry Date: 1989-11
Authors: Boadie W Dunlop; Jared A DeFife; Lauren Marx; Steven J Garlow; Charles B Nemeroff; Scott O Lilienfeld Journal: Int Clin Psychopharmacol Date: 2011-11 Impact factor: 1.659
Authors: Steven D Hollon; Robert J DeRubeis; Jan Fawcett; Jay D Amsterdam; Richard C Shelton; John Zajecka; Paula R Young; Robert Gallop Journal: JAMA Psychiatry Date: 2014-10 Impact factor: 21.596
Authors: E Frank; G B Cassano; P Rucci; W K Thompson; H C Kraemer; A Fagiolini; L Maggi; D J Kupfer; M K Shear; P R Houck; S Calugi; V J Grochocinski; P Scocco; J Buttenfield; R N Forgione Journal: Psychol Med Date: 2010-04-12 Impact factor: 7.723